You L - Search Results

1

Circulating immunological transcriptomic profile identifies DDX3Y and USP9Y on the Y chromosome as promising biomarkers for predicting response to PD-1/PD-L1 blockade.

You L, Xin Z, Na F, Chen M, Wen Y, Li J, Song J, Bai L, Zhai J, Zhou X, Ying B, Zhou J. You L, et al. Chin Med J (Engl). 2025 Jan 2. doi: 10.1097/CM9.0000000000003403. Online ahead of print. Chin Med J (Engl). 2025. PMID: 39748194 No abstract available.

2

Immunogenetic variations predict immune-related adverse events for PD-1/PD-L1 inhibitors.

Xin Z, You L, Na F, Li J, Chen M, Song J, Bai L, Chen J, Zhou J, Ying B. Xin Z, et al. Among authors: you l. Eur J Cancer. 2023 May;184:124-136. doi: 10.1016/j.ejca.2023.01.034. Epub 2023 Feb 23. Eur J Cancer. 2023. PMID: 36917924 Free article.

3

Immunogenetic polymorphisms predict therapeutic efficacy and survival outcomes in tumor patients receiving PD-1/PD-L1 blockade.

Xin Z, You L, Li J, Na F, Chen M, Song J, Bai L, Chen H, Zhai J, Zhou X, Zhou J, Ying B. Xin Z, et al. Among authors: you l. Int Immunopharmacol. 2023 Aug;121:110469. doi: 10.1016/j.intimp.2023.110469. Epub 2023 Jun 11. Int Immunopharmacol. 2023. PMID: 37311357 Free article.

4

Diverse regulated cell death modes predict the immune microenvironment and drug sensitivity in lung adenocarcinoma.

You L, Xin Z, Zhou X, Na F, Zhou J, Ying B. You L, et al. J Cell Physiol. 2023 Nov;238(11):2570-2585. doi: 10.1002/jcp.31109. Epub 2023 Oct 16. J Cell Physiol. 2023. PMID: 37842875

5

A Promising Preoperative Prediction Model for Microvascular Invasion in Hepatocellular Carcinoma Based on an Extreme Gradient Boosting Algorithm.

Liu W, Zhang L, Xin Z, Zhang H, You L, Bai L, Zhou J, Ying B. Liu W, et al. Among authors: you l. Front Oncol. 2022 Mar 4;12:852736. doi: 10.3389/fonc.2022.852736. eCollection 2022. Front Oncol. 2022. PMID: 35311094 Free PMC article.

6

Novel directions of precision oncology: circulating microbial DNA emerging in cancer-microbiome areas.

You L, Zhou J, Xin Z, Hauck JS, Na F, Tang J, Zhou X, Lei Z, Ying B. You L, et al. Precis Clin Med. 2022 Feb 3;5(1):pbac005. doi: 10.1093/pcmedi/pbac005. eCollection 2022 Mar. Precis Clin Med. 2022. PMID: 35692444 Free PMC article. Review.

7

A two-step infection model: From SARS-CoV-2 entry and trafficking to egress and spread.

You L, Ying B. You L, et al. MedComm (2020). 2023 May 31;4(3):e295. doi: 10.1002/mco2.295. eCollection 2023 Jun. MedComm (2020). 2023. PMID: 37274936 Free PMC article. No abstract available.

8

Leveraging circulating microbiome signatures to predict tumor immune microenvironment and prognosis of patients with non-small cell lung cancer.

Zhou X, You L, Xin Z, Su H, Zhou J, Ma Y. Zhou X, et al. Among authors: you l. J Transl Med. 2023 Nov 10;21(1):800. doi: 10.1186/s12967-023-04582-w. J Transl Med. 2023. PMID: 37950236 Free PMC article.

9

Exosomal mRNA in plasma serves as a predictive marker for microvascular invasion in hepatocellular carcinoma.

Xin Z, Chen H, Xu J, Zhang H, Peng Y, Ren J, Guo Q, Song J, Jiao L, You L, Bai L, Wei Y, Zhou J, Ying B. Xin Z, et al. Among authors: you l. J Gastroenterol Hepatol. 2024 Oct;39(10):2228-2238. doi: 10.1111/jgh.16677. Epub 2024 Jul 7. J Gastroenterol Hepatol. 2024. PMID: 38972728

10

The long non-coding RNA HOXA11-AS activates ITGB3 expression to promote the migration and invasion of gastric cancer by sponging miR-124-3p.

You L, Wu Q, Xin Z, Zhong H, Zhou J, Jiao L, Song X, Ying B. You L, et al. Cancer Cell Int. 2021 Oct 29;21(1):576. doi: 10.1186/s12935-021-02255-6. Cancer Cell Int. 2021. PMID: 34715856 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,612 results

Search Page

Filters